Skip to content

Efficacy of combination of Vastiamayantaka ghritha vaginal tampon, Chandraprabha vati and Kegel s exercise in comparison to Chandraprabha vati and Kegel s exercise in urinary incontinence

Efficacy of combination of Vastiamayantaka ghritha yoni pichu, Chandraprabhavati and Kegel s exercise in comparison to Chandraprabha vati and Kegel s exercise in urinary incontinence An open label randomized clinical study - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084869
Enrollment
150
Registered
2025-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N394- Other specified urinary incontinence

Interventions

None listed

Sponsors

Dr.Shweta C Dindur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female patients of age group 30 to 45 years with signs and symptoms of Urinary incontinence 2.UI symptoms of at least 6 months duration 3.24 Hour pad weight greater than 3 g during the screening period 4.A minimum of 1 and no more than 15 UI episodes on any single day and no fewer than 9 total UI episodes over 3 days during the screening period

Exclusion criteria

Exclusion criteria: 1. Patients with congenital anomalies of genitourinary system. 2. Patients with Uterine prolapse 3. Patients with carcinoma of cervix 4. Patients with systemic diseases which may interfere with the course of treatment. 5. Gravid women 6. History of Surgery/Assisted labor 7. History of urethral diverticula; History of urethral sling or anterior prolapse repair 8. Treatment with urethral bulking agents and/or other UI procedure or surgery within the 6 months prior to the Screening Visit 9. Known vesicoureteral reflux, vaginal prolapse beyond the introitus, or other significant pelvic floor abnormalities 10. Urinary incontinence of neurogenic etiology 11. Morbidly obese (body mass index 40 or greater) 12. Chronic hepatitis 13. Hepatic cirrhosis 14. Evidence of active infection with hepatitis B or hepatitis C 15. History of human immunodeficiency virus (HIV) infection

Design outcomes

Secondary

MeasureTime frame
Improved quality of life in patients with urine incontinence & recording of potential ADR if any, though not expected.Timepoint: At baseline, 30th day, 60th day, 90th day

Primary

MeasureTime frame
Reduction in signs and symptoms of Urinary incontinence graded through RUIS ScaleTimepoint: At baseline, 30th day, 60th day, 90th day

Countries

India

Contacts

Public ContactDr Shweta C Dindur

Sri Chandrasekharendra Saraswathi Viswa Mahavidyalaya

drchakravarthy@sjsach.org.in9840109787

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026